Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 10, Number 2, February 2018, pages 106-116


Pattern of Thyroid Lesions in Western Region of Saudi Arabia: A Retrospective Analysis and Literature Review

Figures

Figure 1.
Figure 1. Characteristics of thyroid lesions found by ultrasonography. Panel (a) showing (1) number of nodules, (2) size of the nodules, (3) shape of the nodules, (4) consistency of the nodules, and (5) margins of the nodules. Panel (b) showing (6) US echogenicity of the nodules, (7) blood flow to the nodules, (8) site of the FNA done, (9) calcification of the nodules, and (10) lymph node enlargement in the nodules.
Figure 2.
Figure 2. Ultrasound features of the various types of thyroid lesions. Panel (a) showing adenomatous thyroid lesion with arrows indicating strap muscles (yellow), margin of nodule (green), trachea (white), heterogeneous nodule (red), and internal jugular vein (blue). Panel (b) showing Hashimoto’s thyroiditis (chronic lymphocytic thyroiditis) with arrows indicating multiple tiny hypoechoic nodular lesions (yellow) and strap muscles (white).
Figure 3.
Figure 3. Ultrasound features of a colloid thyroid lesion. Panel (a) showing multiple cystic lesions (white arrows) and strap muscles (yellow). Panel (b) showing lymphoplastc thyroid lesion with arrows indicating cystic changes (white), strap muscles (yellow), and margin of nodule (red).
Figure 4.
Figure 4. Ultrasound features of a malignant thyroid nodule. Malignant thyroid lesions with irregular margins are indicated by white arrow marked hypoechogenic; strap muscles and microcalcification are indicated by yellow and green arrows, respectively.
Figure 5.
Figure 5. Histopathology of the representative cases with various thyroid lesions stained with H&E, Papanicolaou stain, and Diff quick stain. In panel (a), Hashimoto’s thyroiditis showing diffuse lymphoplasmacytic infiltration, lymphoid follicles with germinal centers (yellow), normal thyroid follicular tissue (black arrows) present around lymphoid follicles (Pap stain, × 10). Panel (b) showing germinal centers (green arrow), red blood cells are indicated by black arrows (H&E stain, × 40). Panel (c) is a colloid goiter showing varied sizes of thyroid follicles lined by low cuboidal epithelium (green arrow) and filled by eosinophilic colloid. Blue arrows indicate thyroid follicles (H&E stain, × 20). Panel (d) is an FNA cell block of follicular carcinoma - tumor tissue showing several neoplastic follicles (black arrows). Blood clot surrounds the neoplastic tissue (yellow arrows, H&E × 20).
Figure 6.
Figure 6. Histopathology of the representative cases with neoplastic thyroid lesions stained with H&E, Papanicolaou stain, and Diff quick stain. Panel (a) showing a Diff quick stained slide (× 40), papillae showing clusters of malignant follicular epithelial cells (red arrows). In panel (b), a classic pattern of papillary carcinoma is presented. Photomicrographs (Pap stain, × 40) show papillary structures consisting of many neoplastic follicular epithelial cells with intranuclear cytoplasmic pseudo-inclusions indicated by black arrows. Panel (c), FNA cell block, showing papillary carcinoma (H&E, × 40). Papillary structures consisting of many neoplastic follicular epithelial cells (green arrow) lining the papillae with fibrovascular core (yellow arrow).

Tables

Table 1. Distribution of Thyroid Lesions According to Gender and Age of the Patients
 
Age groups (years)Male (%)Female (%)Total (%)
Pearson Chi-square = 0.068.
< 201 (10)9 (90)10 (5.8)
21 - 304 (14.8)23 (85.2)27 (15.6)
31 - 403 (7.5)37 (92.5)40 (23.1)
41 - 506 (12)44 (88)50 (28.9)
51 - 604 (15.4)22 (84.6)26 (15)
> 614 (20)16 (80)20 (11.6)
Total22 (12.7)151 (87.3)173 (100)

 

Table 2. Distribution of Patients According to Their Nationalities and Gender
 
Origin of patientsMale (%)Female (%)TotalPercent
Saudi19 (86.36)127 (84.10)14684.39
Syrian04 (2.66)42.31
Palestinian01 (0.66)10.58
Egyptian03 (1.99)31.73
Pakistani3 (13.64)6 (3.98)95.2
Yemeni05 (3.31)52.89
Indonesian01 (0.66)10.58
Bangladeshi01 (0.66)10.58
Filipino02 (1.32)21.16
Myanmar01 (0.66)10.58
Total22 (100)151 (100)173100

 

Table 3. Distribution of Thyroid Lesions According to Age Groups and Location
 
Age groups (years)GenderThyroid lobeTotal (%)
RightLeftBothIsthmusDiffuseLN only
< 20Male1000001
Female3330009
Total43300010
21 - 30Male4000004
Female142700023
Total182700027
31 - 40Male0120003
Female15101011037
Total15111211040
41 - 50Male2040006
Female1681810144
Total1882210150
51 - 60Male1120004
Female751000022
Total86120026
> 60Male1030004
Female83500016
Total93800020
Total72 (41.6%)33 (19.1%)64 (37%)2 (1.2%)1 (0.6%)1 (0.6%)173 (100%)
Pearson Chi-square0.5050.7920.4910.806

 

Table 4. Distribution of Benign Nodules According to Age Groups of Patients
 
Age groups (years)Benign nodules (%)Total (%)
Not benignAdenomatousColloidLymphocyticOthers
< 200172010
21 - 3052155027
31 - 4016303040
41 - 5052385050
51 - 6013183126
Total14 (8.1)16 (9.3)124 (71.7)18 (10.4)1 (0.6)173 (100)

 

Table 5. Spectrum of Thyroid Diseases in Different Sexes by Final Diagnosis
 
Thyroid lesionsGender (%)Total (%)
MaleFemale
SOM: suspicious of malignancy.
Non-diagnostic04 (2.65)4 (2.31)
Benign20 (90.92)139 (92.1)159 (91.91)
Atypia01 (0.66)1 (0.6)
SOM1 (4.54)01 (0.6)
Malignant1 (4.54)7 (4.64)8 (4.63)
Total22 (12.72)151 (87.28)173 (100)
Adenomatous nodules3 (15)13 (9.35)16 (10.2)
Colloid nodules16 (80)108 (77.7)124 (77.91)
Lymphocytic (Hashimoto)1 (1)17 (12.24)18 (11.31)
Others01 (0.72)1 (0.63)
Total (benign)20 (12.58)139 (87.42)159 (100)

 

Table 6. Distribution of Thyroid Lesions According to Age Groups in Different Sexes
 
Age groups (years)DiagnosisGender (%)Total (%)
MaleFemale
SOM: suspicious of malignancy.
< 20Benign1 (100)9 (100)10
Total1 (100)9 (100)10
21 - 30Benign2 (50)20 (86.96)22
SOM1 (25)01
Malignant1 (25)3 (13.04)4
Total4 (100)23 (100)27
31 - 40Benign3 (100)36 (97.3)39
Malignant01 (2.7)1
Total3 (100)3740
41 - 50Non-diagnostic03 (6.82)3
Benign6 (100)39 (88.7)45
Malignant02 (4.55)2
Total6 (100)44 (100)50
51 - 60Non-diagnostic01 (4.55)1
Benign4 (100)21 (95.45)25
Total4 (100)22 (100)26
> 60Benign4 (100)1418
Atypia011
Malignant011
Total4 (20)16 (80)20
Grand total22 (12.72)151 (87.28)173 (100)